Global CRO WuXi AppTec has partnered with China’s Fudan University to bring WuXi NextCODE's population human genomics database system and integrated research and clinical solutions to the Fudan-led Collaborative Innovation Center of Genetics and Development (CICGD) as an enterprise partner. The partnership will empower CICGD scientists to perform gene sequencing and bioinformatics analysis with unparalleled speed and precision, thereby accelerating research, clinical diagnosis and treatment of rare inherited diseases and malignant tumors.

As a wholly owned subsidiary of WuXi AppTec, WuXi NextCODE offers its global clients fully integrated turnkey solutions for genomic medicine, from CLIA sequencing to bioinformatics, clinical interpretation and diagnostic test development and delivery. WuXi NextCODE's technology is being used to analyze and manage whole-genome data on 350,000 people.

Fudan led the establishment of CICGD in 2012 under the auspices of the Higher Education Institution Innovation Improvement Plan implemented by China's Ministry of Education and Ministry of Finance. The CICGD brings together several other Chinese research institutions, including Shanghai Jiaotong University, Nanjing University, Zhongshan University, Central South University, the Shanghai Institutes for Biological Sciences, the Institute of Genetics and Developmental Biology and the Beijing Institute of Genomics. Collectively, these institutions are dedicated to researching scientific questions in genetics and developmental biology, as well as evaluating their impact on human health.